Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uterine Cervix Adenosquamous Carcinoma”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Large-scale testing (Phase 3)Study completedNCT00003945
What this trial is testing

Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 400
Testing effectiveness (Phase 2)Study completedNCT01026792
What this trial is testing

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT01266447
What this trial is testing

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+5 more
National Cancer Institute (NCI) 27
Not applicableUnknownNCT00813007
What this trial is testing

Radical Trachelectomy for Women With Early Stage Cervical Cancer

Who this might be right for
Cervical Cancer
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)WithdrawnNCT01301612
What this trial is testing

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Who this might be right for
CarcinomaAdenocarcinomaUterine Cervix Adenosquamous Carcinoma
Eurofarma Laboratorios S.A.
Early research (Phase 1)Study completedNCT02164461
What this trial is testing

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

Who this might be right for
Effects of ImmunotherapyMetastatic/Recurrent Cervical CancerCervical Adenocarcinoma+6 more
Advaxis, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00003017
What this trial is testing

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix

Who this might be right for
Cervical Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT01281852
What this trial is testing

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more
National Cancer Institute (NCI) 37
Large-scale testing (Phase 3)Study completedNCT00803062
What this trial is testing

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 452
Early research (Phase 1)Study completedNCT00003377
What this trial is testing

Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 29
Not applicableStudy completedNCT01759355
What this trial is testing

Hybrid PET/MR in the Therapy of Cervical Cancer

Who this might be right for
Cervix CarcinomaCervical Squamous Cell CarcinomaCervical Adenosquamous Carcinoma
UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)WithdrawnNCT03834571
What this trial is testing

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Study completedNCT00416455
What this trial is testing

Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Small Cell Carcinoma+11 more
National Cancer Institute (NCI) 384
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07276360
What this trial is testing

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

Who this might be right for
Cervical CancerCervix CancerCervical Adenocarcinoma+2 more
Uganda Cancer Institute 278
Testing effectiveness (Phase 2)Study completedNCT02394652
What this trial is testing

The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial

Who this might be right for
Uterine Cervical NeoplasmsSquamous Cell CarcinomaAdenocarcinoma+1 more
University Health Network, Toronto 16
Testing effectiveness (Phase 2)Study completedNCT00039442
What this trial is testing

Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma
Gynecologic Oncology Group 21
Large-scale testing (Phase 3)Active Not RecruitingNCT02466971
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Who this might be right for
Advanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 450
Testing effectiveness (Phase 2)Study completedNCT00012012
What this trial is testing

Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer

Who this might be right for
Cervical CancerRadiation Toxicity
Radiation Therapy Oncology Group 45
Testing effectiveness (Phase 2)Study completedNCT00309959
What this trial is testing

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+2 more
Gynecologic Oncology Group 37
Testing effectiveness (Phase 2)Study completedNCT01266460
What this trial is testing

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+1 more
Gynecologic Oncology Group 54
Load More Results